Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Advanced Enzyme Technologies Limited Regulatory Filings 2021

Jul 31, 2021

62369_rns_2021-07-31_2cad7f23-1c03-4b8e-bf81-b1e8d9bca46b.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

July 31, 2021

BSE Limited

P. J. Towers, Dalal Street, Mumbai - 400 001 Scrip Code-540025

National Stock Exchange of India Ltd., Exchange Plaza, Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Trading Symbol-ADVENZYMES

Dear Sir/Madam,

Sub: Intimation of Board Meeting and Closure of Trading Window

Intimation of Board Meeting:

This is to inform that the Meeting of Board of Directors of Company is scheduled to be held through video conference on Saturday, August 07, 2021 , inter alia , to consider and approve Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2021.

Closure of Trading Window:

Further to our letter dated June 30, 2021 intimating closure of Trading Window from July 01, 2021, we wish to inform you that for the above mentioned purpose, the “Trading Window” for dealing in the Securities of the Company shall continue to remain closed up to August 09, 2021.

Copy of this intimation / notice may be accessed on the Company’s website at www.advancedenzymes.com and may also be accessed on the website of Stock Exchange i.e. www.bseindia.com and www.nseindia.com.

You are requested to kindly take a note of the same.

Thanking you, Yours faithfully,

For Advanced Enzyme Technologies Limited

Digitally signed by SANJAY SANJAY PRAKASH PRAKASH BASANTANI BASANTANI Date: 2021.07.31 13:12:00 +05'30'

Sanjay Basantani

Company Secretary and Head – Legal